- Headquarters
- Boulder, Colorado
- Employees
- 51–200
- Founded
- 1998
- Business Model
- B2B
About
Array BioPharma Inc. (NASDAQ: ARRY) was a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients with cancer, with sites in Boulder, Colorado; Cambridge, Massachusetts; and Morrisville, North Carolina. Its pipeline included binimetinib, encorafenib, selumetinib (with AstraZeneca), and larotrectinib (with Loxo Oncology), among other partnered and Array-owned programs. Pfizer acquired Array BioPharma in 2019 for roughly $11.4 billion for its cancer drug portfolio.
Summary
Array Biopharma is a Biotech company based in Boulder, United States, founded in 1998.
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/array-biopharma"><img src="https://indexed.vc/api/badge/company/array-biopharma" alt="Array Biopharma on Indexed.vc" width="260" height="76" /></a>